Profund Advisors’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,650
Closed -$179K 1019
2023
Q2
$179K Buy
2,650
+795
+43% +$329K 0.01% 1003
2023
Q1
$865K Buy
+1,855
New +$981K 0.05% 336
2021
Q3
Sell
-680
Closed -$453K 1380
2021
Q2
$453K Sell
680
-13
-2% -$7.49K 0.02% 738
2021
Q1
$601K Sell
693
-61
-8% -$64.9K 0.02% 491
2020
Q4
$699K Buy
754
+76
+11% +$79.9K 0.03% 415
2020
Q3
$697K Sell
678
-88
-11% -$94.7K 0.04% 362
2020
Q2
$776K Buy
766
+122
+19% +$113K 0.04% 307
2020
Q1
$559K Sell
644
-267
-29% -$265K 0.04% 336
2019
Q4
$977K Buy
911
+117
+15% +$119K 0.04% 357
2019
Q3
$734K Sell
794
-25
-3% -$27.5K 0.04% 433
2019
Q2
$925K Sell
819
-71
-8% -$77.7K 0.04% 392
2019
Q1
$1.21M Buy
890
+2
+0.2% +$2.71K 0.06% 294
2018
Q4
$1.03M Sell
888
-217
-20% -$244K 0.06% 271
2018
Q3
$1.68M Buy
+1,105
New +$1.7M 0.06% 244

Other funds holding KYNB

Profund Advisors's KYNB Position: Q3 2023 in Review

Profund Advisors sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 2,650 shares — an estimated $179K sold.

Profund Advisors first reported a position in KYNB in Q3 2018 and held it in 14 quarters. The position peaked at $1.68M in Q3 2018. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Profund Advisors reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Profund Advisors sold 2,650 Kyntra Bio shares in Q3 2023, an estimated $179K.
  • Profund Advisors first reported a position in Kyntra Bio in Q3 2018 and held it in 14 quarters.
  • Profund Advisors's Kyntra Bio position peaked at $1.68M in Q3 2018.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Profund Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.